Adalank

I-Adalank iyi-analogue ye-peptide yokwenziwa ye-selank, ngokuguqulwa kwamakhemikhali okuhlosiwe.

 

 

I-SKU: 198803 Isigaba:
Yabelana ngothando lwakho

I-Adalank iyi-analogue ye-peptide yokwenziwa selank, ngokuguqulwa kwamakhemikhali okuhlosiwe.

I-peptide yakhelwe njenge-a okuphuma kokunye kwe i-nootropic izidakamizwa Selank, ngokungezwa kwe-acetylated N-terminal function ethuthukisa ukwakheka kwayo kwe-adamantane-like sterically-constraining.

Lokhu kuguqulwa kusebenza njenge-synergistic potentiator enamandla ye-anxiolytic – inhlanganisela ye-nootropic Selank.

Igwema abampofu bakaSelank umgoqo wegazi-ubuchopho (BBB) ukungena, ngalokho kwandisa isimiso sezinzwa esiphakathi umsebenzi we-Adalank kakhulu.

Ukwengezwa kwe- iqembu le-acetyl iqeda ukukhokhiswa okuhle kweqembu le-amino lamahhala le-N-terminal futhi yehlise inani eliphelele le-peptide.

Lokhu kulungiswa kwe-physicochemical kuthuthukisa i- iphuzu le-isoelectric kanye nezakhiwo ze-Adalank, ukunciphisa ukusebenzisana okungaqondile kwe-electrostatic.

Ngenxa yalokho, ingqamuzana lomuthi linqamula umgoqo wegazi nobuchopho kalula futhi lifinyelele ohlelweni lwezinzwa olumaphakathi.

Ngaphezu kwalokho, i-acetylation ivikela i-Adalank kusuka i-exopeptidase ukucekelwa phansi futhi  nyusa ngokuphawulekayo isigamu sempilo yayo ye-vivo.

Lokhu kunikeza inzuzo yamazinga egazi okwelapha isikhathi eside futhi kunciphisa umthamo ovamile.

Ukufakwa kwe idamantane idala “umongo wokuguqula” ozinzile ku-peptide ye-Adalank.

Lokhu kunikeza umumo omisiwe wendawo ku-peptide yomugqa eguquguqukayo ekuqaleni., ukukhuthaza ukuhambisana kwe-stereochemical okudingekile emsebenzini webhayoloji ngisho sesimweni sakho esingaboshiwe.

Lokhu kulithuthukisa kakhulu ikhono lika-Adalank lokuwela umgoqo wegazi nobuchopho.

Ngaphezu kwalokho, I-Adalank ibonisa imiphumela ethile ye-immunomodulatory.

Ukulandelana

ac-thr-lys-pro-arg-pro-gly-pro-Adamanane-nh2

Inombolo ye-CAS

/

I-Molecular Formula

I-C46H75N13O10

Isisindo samangqamuzana

970.19

Ucwaningo lwe-Adalank:

1.Indlela Yokwenza

Ukusebenza kahle, Isakhiwo esiqinile se-Adalank sihambisana kakhulu  ne ukuguqulwa kwe-allosteric indawo ye I-GABA_A umamukeli iyunithi ye-alpha, enikeza ngamandla i-anxiolytic imiphumela.

Ngaphezu kwalokho, i-adamantane moiety yenza ukusebenzisana kwe-hydrophobic ku- I-NMDA receptor indawo yesiteshi ukuya ekuthelelekeni okumaphakathi kwe-calcium nokuvikela ekulimaleni kwe-excitotoxic.

Lesi sakhiwo sinamandla okuthi neuroprotection kumamodeli okulimala kobuchopho be-ischemic kanye ukucindezeleka kwangemva kwenhlekelele (I-PTSD).

2.I-Anxiolytic Effects

Njengokususelwe okulungiselelwe kwe-Selank, I-Adalank igcina ukusebenzisana okuphezulu nesayithi ye-benzodiazepine ku-GABA_A receptor α-subunit.

Nokho, i-N-terminal acetylation kanye ne-adamantane scaffold susa imodi yokubopha kusuka “ku-flexible kufanelekile” kuya “kudokheni oluqondile oluqinile”.

Lokhu kuthuthukisa i-GABAergic inhibitory neurotransmission, ukukhuthaza ukungena kwe-chloride kanye nokunciphisa ngokushesha umsebenzi kuma-hyperactive amygdala-prefrontal cortex neural circuits.

Ngokuphambene ne-benzodiazepines, I-Adalank ikhombisa ukukhetha okuphezulu kwe-receptor subtype, inika amandla imiphumela eqhubekayo ye-anxiolytic ngaphandle kwe-sedation, ukuphumula kwemisipha, noma amandla okuba umlutha ahlobene nezidakamizwa zendabuko.

Yakho inkomba yokwelapha kuyinto 3 ku 5 izikhathi ezibanzi, ukusekela ukuphathwa kwesikhathi eside kwe ukukhathazeka okujwayelekile kanye nezinkinga zokukhathazeka zesimo.

3.Ukuthuthukisa Ingqondo Nokuthuthukiswa Kwenkumbulo

I-Adalank ivimbela ngokuphumelelayo ukusebenza kwendlela yokuvuvukala ye-NF-κB futhi iyanda I-BDNF mRNA inkulumo nge 50%-80% kwe i-hippocampus.

Lokhu kuholela ekusebenziseni umfula ongezansi Akt/I-CREB izindlela zokusayina, ukwenza lula ukungeniswa nokugcinwa kwe-LTP.

Ithuthukisa kakhulu ukugcinwa kwenkumbulo ngaphakathi ukugwema ukwenza okuthile izivivinyo, kuthuthukisa ukufunda kwendawo ku UMaze wamanzi kaMorris, kanye nokuphikisana i-scopolamine-ukulimala kwe-cholinergic.

Idatha ye-preclinical ibonisa ukuthi i-Adalank inciphisa amaphutha enkumbulo yokusebenza ngo 40%-60% futhi kunciphisa ukuncipha kwenkumbulo yemvelo ezilwaneni esezikhulile, ukuphakamisa ukusebenza ezinkingeni zokufunda, ukukhubazeka kwengqondo okuncane, kanye - nokuncipha kwenkumbulo ehlobene neminyaka.

4.I-Neuroprotective Effects

Isakhiwo se-adamantane ku-Adalank silingisa isenzo se i-memantine, esebenza njengomuntu ongaqhudelani I-NMDA receptor umphikisi obangela ukuvinjwa okuncike ku-voltage kweziteshi ezivulekile kanye nokulawulwa ngokomzimba kokungena kwe-calcium.

Yehlisa ukungena kwe-pathological Ca²⁺ ngo-60–70% ngaphandle kokuphazamisa ukusayina kwe-Ca²⁺ ye-physiological synaptic, ukufeza iphrofayili ye-neuroprotective ekhethiwe ngaphandle kokuphazamisa umsebenzi ojwayelekile.

Ngakho, izifundo zangaphambi komtholampilo ziqokomisa amandla abalulekile ka-Adalank okuhumusha okungenelela kusenesikhathi ku-stroke eyingozi, ukulimala komgogodla, futhi izifo ze-neurodegenerative.

I-COA

I-HPLC

MS

(1) Siyafuna, C. R.; Emhlophe, C. M. Ama-Sedative-Hypnotic Agents Anomthelela kuma-Gamma-Aminobutyric Acid Receptors: Gxila ku-Flunitrazepam, I-Gamma-Hydroxybutyric Acid, Phenibut, kanye noSelank. J Clin Pharmacol 2021, 61 Suppl 2, I-S114-S128. I-DOI: 10.1002/jcph.1922 Kusuka ku-NLM M

(2) Uyinto ehluphekayo, A.; Kolomin, T.; U-Andreeva, L.; Bondarenko, E.; Myasoedov, N.; Slominsky, P.; Shadrina, M. I-Peptide Selank Ithuthukisa Umphumela We-Diazepam Ekwehliseni Ukukhathazeka Ezimweni Ezingalindelekile Zengcindezi Encane Engapheli Kumagundane. I-Behav Neurol 2017, 2017, 50910

(3) Phina, L. G.; Nadorova, A. V.; I-Antipova, T. A.; Kruglov, S. V.; Kudrin, V. S.; Durnev, A. D. Selank, I-analogue ye-Peptide ye-Tuftsin, Ivikela Ekonakaleni Kwenkumbulo Ye-Ethanol Ngokulawula Okuqukethwe kwe-BDNF ku-Hippocampus kanye ne-Prefrontal Cortex

(4) Phina, L. G.; Nadorova, A. V.; Seredenin, S. B. I-Selank Ivimbela I-Ethanol-Induced Hyperlocomotion kanye Nokubonakaliswa Kokuzwela Ukuziphatha ku-DBA/2 Amagundane. Inkunzi Exp Biol Med 2016, 162 (1), 56-59. I-DOI: 10.1007/s10517-016-3544-6 Kusuka ku-NLM Medline.

(5) Izindleko, N. V.; I-Sokolov, O.; Gabaeva, M. V.; Grivennikov, I. A.; U-Andreeva, L. A.; Miasoedov, N. F.; Zozulia, A. A. [I-Semax ne-selank ivimbela ama-enzyme e-enkephalin-degrading ku-serum yomuntu]]. Bioorg Khim 2001, 27 (3), 180-183. I-DOI: 10.1023/a:10113730028

(6) Angazi, G. G.; Teleshova, E. S.; Bochkarev, V. K.; Koschelev, V. V.; Syunyakov, T. S. P.3.036 Inoveli ye-anxiolytic Selank: Imiphumela yezilingo zomtholampilo zeSigaba II. I-European Neuropsychopharmacology 2005, 15, I-S159-S160. I-DOI: 10.1016/s0924-977x(05)80332-3.

(7) Slominsky, P. A.; Shadrina, M. I.; Kolomin, T. A.; Stavrovskaya, A. V.; I-Filatova, E. V.; U-Andreeva, L. A.; I-Illarioshkin, S. N.; Myasoedov, N. F. I-Peptides semax kanye ne-selank ithinta ukuziphatha kwamagundane nge-6-OHDA eyenziwe nge-PD-like parkinsonism. Kuze kube yi-Biol Sc

(8) I-Sollertinskaja, T. N.; Shorokhov, M. V.; Myasoedov, N. F. Imiphumela ye-cerebroprotective ye-Semax ne-Selank kuma-primates ezinhlobonhlobo ze-neurosis. Ijenali yamazwe ngamazwe ye-Psychophysiology 2008, 69 (3). I-DOI: 10.1016/j.ijpsycho.2008.05.356.

Ukulandelana:

ac-thr-lys-pro-arg-pro-gly-pro-Adamanane-nh2

I-CAS:

N/A

M.W:

970.19 g/mol

Ikhaya Sesha Whatsapp Amasevisi Umkhiqizo